Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 1 32Phase 1/2 17Phase 3 3Phase 2/3 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 9Other neoplasm 4Myeloid 3Lymphoid 1Genitourinary 1

Conditions

Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Wilms Tumor 1GATA2 Deficiency 1

Interventions

fludarabine phosphate 5Cyclophosphamide 5Azacitidine 4Thiotepa 3Stem Cell Transplantation 3Melphalan 3Gemtuzumab 3Decitabine 3Cytarabine 3Busulfan 3venetoclax 2Radiotherapy 2Methylprednisolone 2Interferon alpha-2 2Injections 2Filgrastim 2Etoposide 2Emapalumab 2Cyclosporine 2Cladribine 2Antilymphocyte Serum 2vosaroxin 1vedolizumab 1trametinib 1tipifarnib 1thymoglobulin 1peginterferon alfa-2b 1peginterferon alfa-2a 1nilotinib 1midostaurin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Decitabine × Myeloid × Clear all
NCT03092674 2025-01-16

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 2/3 Completed
76 enrolled 16 charts
MyeloidOther hematologic neoplasm

GATA2 Deficiency, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02272478 2020-01-23

AML18

Cardiff University

Phase 2/3 Unknown
1,600 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01809392 2013-03-12

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

The First Affiliated Hospital of Soochow University

Phase 2/3 Unknown
15 enrolled
GenitourinaryMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Wilms Tumor, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡